Home › Compare › DROP vs JNJ

DROP vs JNJ: Dividend Comparison 2026

DROP yields 71428.57% · JNJ yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 DROP wins by $1.6804617092236922e+25M in total portfolio value
10 years
DROP
DROP
● Live price
71428.57%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.6804617092236922e+25M
Annual income
$16,758,464,082,723,930,000,000,000,000,000.00
Full DROP calculator →
JNJ
Johnson & Johnson
● Live price
2.14%
Share price
$242.49
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.5K
Annual income
$4,749.88
Full JNJ calculator →

Portfolio growth — DROP vs JNJ

📍 DROP pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodDROPJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, DROP + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
DROP pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DROP
Annual income on $10K today (after 15% tax)
$6,071,428.57/yr
After 10yr DRIP, annual income (after tax)
$14,244,694,470,315,339,000,000,000,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$182.28/yr
After 10yr DRIP, annual income (after tax)
$4,037.40/yr
At 15% tax rate, DROP beats the other by $14,244,694,470,315,339,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DROP + JNJ for your $10,000?

DROP: 50%JNJ: 50%
100% JNJ50/50100% DROP
Portfolio after 10yr
$8.402308546118461e+24M
Annual income
$8,379,232,041,361,964,000,000,000,000,000.00/yr
Blended yield
99.73%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

DROP
No analyst data
Altman Z
142.0
Piotroski
2/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-5.7% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DROP buys
0
JNJ buys
0
No recent congressional trades found for DROP or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricDROPJNJ
Forward yield71428.57% ✓2.14%
Annual dividend / share$2.00$5.20 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28% ✓
Portfolio after 10y$1.6804617092236922e+25M$30.5K ✓
Annual income after 10y$16,758,464,082,723,930,000,000,000,000,000.00 ✓$4,749.88
Total dividends collected$1.6801590475897682e+25M$15.6K ✓
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: DROP vs JNJ ($10,000, DRIP)

YearDROP PortfolioDROP Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$7,153,557$7,142,857.14$10,594$274.49+$7.14M → DROP
2$4,783,059,608$4,775,405,302.31$11,294$360.69+$4783.05M → DROP
3$2,989,196,089,253$2,984,078,215,471.53$12,133$476.91+$2989196.08M → DROP
4$1,746,108,740,720,723$1,742,910,300,905,223.00$13,156$635.42+$1746108740.71M → DROP
5$953,366,906,359,837,700$951,498,570,007,266,600.00$14,432$854.61+$953366906359.82M → DROP
6$486,546,837,026,708,500,000$485,526,734,436,903,500,000.00$16,056$1,162.76+$486546837026708.50M → DROP
7$232,096,820,383,666,640,000,000$231,576,215,268,048,070,000,000.00$18,175$1,604.53+$232096820383666624.00M → DROP
8$103,489,940,016,498,150,000,000,000$103,241,596,418,687,620,000,000,000.00$21,009$2,252.68+$103489940016498147328.00M → DROP
9$43,133,653,750,454,530,000,000,000,000$43,022,919,514,636,880,000,000,000,000.00$24,911$3,229.73+$4.313365375045453e+22M → DROP
10$16,804,617,092,236,920,000,000,000,000,000$16,758,464,082,723,930,000,000,000,000,000.00$30,458$4,749.88+$1.6804617092236922e+25M → DROP

DROP vs JNJ: Complete Analysis 2026

DROP — Stock

Fuse Science, Inc. operates a cloud-based customer service software platform. The company also produces and sells sports nutrition and performance products. Its products include SkyPorts, a drone support technology and energy demand network that enables long distance flight required for drone-based commerce without the need for drones to return every 15 minutes to recharge; and XTRAX, a remote monitoring system designed to measure the production of solar and other renewable energy systems, as well as transmit the data via the cellular and radio frequency. The company was formerly known as Double Eagle Holdings, Ltd. and changed its name to Fuse Science, Inc. in December 2011. Fuse Science, Inc. was incorporated in 1988 and is based in Jacksonville, Florida.

Full DROP Calculator →

JNJ — Healthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this DROP vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DROP vs SCHDDROP vs JEPIDROP vs ODROP vs KODROP vs MAINDROP vs ABBVDROP vs MRKDROP vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.